New prevention measures for RSV have led to a major drop in hospitalizations among infants, according to a new CDC study.

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

RSV infections in children needing primary care cause high economic impact due to outpatient costs and parental work absences ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

Universal immunisation with nirsevimab significantly reduces hospitalizations and paediatric intensive care admissions for ...

The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

A new study reveals that respiratory syncytial virus (RSV) hospitalizations have significantly higher risks for heart ...

There have been almost 50,000 cases of RSV recorded this year, but only a select group can access the free vaccine, with ...